Description: This 1991 panel discussion is about the NAIC and HIAA models, as well as state regulations proposed or adopted to regulate small group underwriting and rate guidelines. From the Record of the Society of Actuaries Vol. 17, No. 3A.

Description: This is a discussion about medical care insurance rating including morbidity, impact of group size and underwriting transfer cases. From Transactions of Society of Actuaries 1965, Vol. 17 Pt. 2, No. 47 AB

Description: This 1991 open forum discussion is about the resource-based relative value scale [RBRVS] and its impact on physician fee trends [Medicare and non-Medicare], physician specialization, utilization, Medicare supplement plans, employer plans [active and retired], HMOs, and physicians and senior citizens. From the Record of the Society of Actuaries Vol. 17, No. 3A.

Description: This 1991 panel discussion is about medical claims management and keeping up with changes in technology. The panelists discuss the use of artificial intelligence in claims processing, 'intelligent' coverage cards, and code gaming problems. From the Record of the Society of Actuaries Vol. 17, No. 4B.

Description: This 1991 panel discussion is about mid-size and large group medical issues, including: 1. Managing the underwriting cycle, 2. Effectively managing the risk, 3. Controlling medical costs, 4. Financial arrangements offered to control or shift risk [i.e., Administrative Services Only [ASO] and minimum premium contracts], and 5. The effect of the Resource-Based Relative Value Schedule [RBRVS] on provider fees and plan costs. From the Record of the Society of Actuaries Vol. 17, No. 4A.

Description: At this presentation, the panelists address the following questions: 1. How is health insurance risk measured? 2. How and why do surplus requirements differ between health insurance and life insurance? 3. How and why do surplus requirements differ among health insurers [e.g., Commercial, Blue Cross, HMO] and among health insurance products? 3. What are some of the current techniques being used by health insurers for determining target or required surplus and for managing surplus? 4. How do the rating agencies view surplus requirements for health insurers? From the Record of the Society of Actuaries Vol. 17, No. 3A.

Description: This 1991 panel discussion about individual health rate filings asks the following seven questions and answers each pro and con: 1. Should individual accident and health be guaranteed renewable? 2. Should there be rate increase caps? 3. Should duration rating be permitted? 4. Should optional pre-filing be permitted? 5. Should loss ratios be increased? 6. Should the pending small-group regulation laws apply to the individual policy area? 7. Should the loss ratio be the only determinant in the approval of a rate change? From the Record of the Society of Actuaries Vol. 17, No. 4B.

Description: The presenters will discuss the range of draft repeal/repair/replace legislation proposed to date, the elements most likely to be included in the final law, and possible temporary and transitional measures to be taken. They will share their findings regarding the impact on the industry of these changes using the most up to date data and modeling available.

Description: Health care is a complex market with a wide variety of stakeholders. These stakeholders have diverse business needs, requiring complicated data-driven decisions. The analytics and research supporting these decisions are often dependent on the availability of real-world data (RWD), which includes a wide variety of data capture technology and data reflecting treatment, clinical outcomes, and costs of health care in real treatment settings (e.g.,, outside of controlled clinical trials). The goal of this panel discussion is to explore how existing and emerging sources of RWD can enhance benefit design, improve risk assessment, influence treatment decisions, and advance the measurement of clinical, humanistic, and financial outcomes. The diverse speaker panel includes actuarial and non-actuarial perspectives, representing the pharmaceutical industry, a health-care services business, and academia. The panel will describe the decision-making that drives their individual needs to use RWD, identify current and developing RWD sources, provide examples of analyses using RWD, and discuss how emerging RWD may influence actuarial analytics and potentiate the development of new interdisciplinary methods and value drivers.

Description: Insurance commissioners and deputy insurance commissioners will discuss current topics including health care reform, life insurance issues, risks in the major medical markets, voluntary products and other topics.